Vaccination to blood donors

Rodríguez García, Juan; Domingo Morera, José M.; García-Erce, José Antonio

doi:10.1016/j.medcle.2021.04.016

array:24 ["pii" => "S2387020622000110" "issn" => "23870206" "doi" => "10.1016/j.medcle.2021.04.016" "estado" => "S300" "fechaPublicacion" => "2022-02-11" "aid" => "5689" "copyright" => "Elsevier España, S.L.U.. All rights reserved" "copyrightAnyo" => "2021" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Med Clin. 2022;158:142-4" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "Traduccion" => array:1 [ "es" => array:19 [ "pii" => "S0025775321002566" "issn" => "00257753" "doi" => "10.1016/j.medcli.2021.04.013" "estado" => "S300" "fechaPublicacion" => "2022-02-11" "aid" => "5689" "copyright" => "Elsevier España, S.L.U." "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Med Clin. 2022;158:142-4" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "es" => array:10 [ "idiomaDefecto" => true "cabecera" => "Carta al Editor" "titulo" => "Vacunación a donantes de sangre" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "142" "paginaFinal" => "144" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Vaccination to blood donors" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Juan Rodríguez-García, José M. Domingo Morera, José Antonio García-Erce" "autores" => array:3 [ 0 => array:2 [ "nombre" => "Juan" "apellidos" => "Rodríguez-García" ] 1 => array:2 [ "nombre" => "José M." "apellidos" => "Domingo Morera" ] 2 => array:2 [ "nombre" => "José Antonio" "apellidos" => "García-Erce" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S2387020622000110" "doi" => "10.1016/j.medcle.2021.04.016" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2387020622000110?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0025775321002566?idApp=UINPBA00004N" "url" => "/00257753/0000015800000003/v1_202202020734/S0025775321002566/v1_202202020734/es/main.assets" ] ] "itemSiguiente" => array:19 [ "pii" => "S2387020622000122" "issn" => "23870206" "doi" => "10.1016/j.medcle.2021.04.017" "estado" => "S300" "fechaPublicacion" => "2022-02-11" "aid" => "5694" "copyright" => "Elsevier España, S.L.U." "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Med Clin. 2022;158:144-5" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "Letter to the Editor" "titulo" => "Acute fibrinous and organizing pneumonia" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "144" "paginaFinal" => "145" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Neumonía organizada fibrinoide aguda" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Daniela García-Huertas, Alejandro López-Fernández, Inmaculada De Dios-Chacón" "autores" => array:3 [ 0 => array:2 [ "nombre" => "Daniela" "apellidos" => "García-Huertas" ] 1 => array:2 [ "nombre" => "Alejandro" "apellidos" => "López-Fernández" ] 2 => array:2 [ "nombre" => "Inmaculada" "apellidos" => "De Dios-Chacón" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S002577532100261X" "doi" => "10.1016/j.medcli.2021.04.018" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S002577532100261X?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2387020622000122?idApp=UINPBA00004N" "url" => "/23870206/0000015800000003/v1_202202040749/S2387020622000122/v1_202202040749/en/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S2387020622000134" "issn" => "23870206" "doi" => "10.1016/j.medcle.2021.04.018" "estado" => "S300" "fechaPublicacion" => "2022-02-11" "aid" => "5698" "copyright" => "Elsevier España, S.L.U." "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Med Clin. 2022;158:142" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "Letter to the Editor" "titulo" => "Methemoglobinemia secondary to consumption of poppers" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "142" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Metahemoglobinemia secundaria al consumo de poppers" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Elena Díez Urdiales, Ana Esteban Molina, Naiara Gargallo Gasca" "autores" => array:3 [ 0 => array:2 [ "nombre" => "Elena" "apellidos" => "Díez Urdiales" ] 1 => array:2 [ "nombre" => "Ana" "apellidos" => "Esteban Molina" ] 2 => array:2 [ "nombre" => "Naiara" "apellidos" => "Gargallo Gasca" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0025775321002657" "doi" => "10.1016/j.medcli.2021.04.022" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0025775321002657?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2387020622000134?idApp=UINPBA00004N" "url" => "/23870206/0000015800000003/v1_202202040749/S2387020622000134/v1_202202040749/en/main.assets" ] "en" => array:15 [ "idiomaDefecto" => true "cabecera" => "Letter to the Editor" "titulo" => "Vaccination to blood donors" "tieneTextoCompleto" => true "saludo" => "Dear Editor:" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "142" "paginaFinal" => "144" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Juan Rodríguez García, José M. Domingo Morera, José Antonio García-Erce" "autores" => array:3 [ 0 => array:3 [ "nombre" => "Juan" "apellidos" => "Rodríguez García" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "a" "identificador" => "aff0005" ] ] ] 1 => array:3 [ "nombre" => "José M." "apellidos" => "Domingo Morera" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "b" "identificador" => "aff0010" ] ] ] 2 => array:4 [ "nombre" => "José Antonio" "apellidos" => "García-Erce" "email" => array:2 [ 0 => "ja.garcia.erce@navarra.es" 1 => "jagarciaerce@gmail.com" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "c" "identificador" => "aff0015" ] 1 => array:2 [ "etiqueta" => "*" "identificador" => "cor0005" ] ] ] ] "afiliaciones" => array:3 [ 0 => array:3 [ "entidad" => "Servicio de Medicina Preventiva, Hospital Universitario Son Espases, Palma de Mallorca, Spain" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Banco de Sangre y Tejidos de Aragón, Zaragoza, Spain" "etiqueta" => "b" "identificador" => "aff0010" ] 2 => array:3 [ "entidad" => "Banco de Sangre y Tejidos de Navarra, Servicio Navarro de Salud, Osasunbidea, Pamplona, España; Grupo Español de Rehabilitación Multimodal (GERM), Instituto Aragonés de Ciencias de la Salud, Zaragoza, Spain; PBM Group, Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain" "etiqueta" => "c" "identificador" => "aff0015" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Vacunación a donantes de sangre" ] ] "textoCompleto" => ""I cannot imagine that an example of philanthropy more noble and broader than this is provided in the annals of history".Edward Jenner (on the Royal Vaccine Philanthropic Expedition or Balmis Expedition)We have read with interest the editorial by Drs. Dal-Ré and Camps.<a class="elsevierStyleCrossRef" href="#bib0005">1</a> We share with the authors the 3 procedural principles they advocate: "fairness in prioritisation, transparency and evidence-based". The decision to prioritize one population group over another to receive the SARS-CoV-2 vaccine is neither easy nor straightforward and must take into account scientific evidence, ethics, and deliverability. From an ethical perspective, prioritisation should maximise benefits and reduce harm, be fair and transparent, and address health inequalities. Most Western countries, including our own, should have developed phased vaccination plans based on these principles.<a class="elsevierStyleCrossRefs" href="#bib0005">1,2</a> These authors, taking into account 4 allocation criteria, propose 4 allocation phases.<a class="elsevierStyleCrossRef" href="#bib0005">1</a> According to them, in phase 1a, high-risk health and social care workers, transport and environmental services at risk should be vaccinated; then, in phase 1b, high-risk patients and people over 65 years of age who live with many people.<a class="elsevierStyleCrossRef" href="#bib0005">1</a> In this sense, it is in line with the Consensus Document of the Spanish Society of Preventive Medicine,<a class="elsevierStyleCrossRef" href="#bib0015">3</a> which has been endorsed by more than 45 Spanish scientific societies, which, through FACME, have asked the Ministry of Health to use it as a basis for strategic decisions on the SARS-CoV-2 vaccination campaign in Spain.In this regard, the US Immunization Practices Advisory Committee, with maximum transparency, applying the ethical principle of "maximizing benefits and minimizing harms" asked: Which groups are most at risk of SARS-CoV-2 infection, symptomatic COVID-19 disease, hospitalisation and mortality? Which groups are essential for COVID-19 response, and which groups are essential for maintaining critical societal functions? The first of the 4 groups chosen for preferential vaccination was the one that preserves health care services essential to the COVID-19 response and the overall health care system 2. Indeed, the World Health Organization (WHO) has warned of the risk of neglecting other non-communicable diseases (NCDs).<a class="elsevierStyleCrossRef" href="#bib0020">4</a> “COVID-19 is interacting with NCDs and inequalities to form the 'perfect storm' of avoidable death and suffering". It thus states that: "Taking appropriate action on NCDs now can save lives and reduce health disparities, strengthen resilience to COVID-19 and future pandemics, and help restore progress in achieving the sustainable development goals (SDGs) broadly. Opportunities for scaling up action on NCDs should be taken both immediately and as part of longer-term efforts to strengthen systems for health”.<a class="elsevierStyleCrossRef" href="#bib0020">4</a> WHO has recommended prioritizing essential health services and adapting to changing contexts and needs. To avoid indirect morbidity and mortality and prevent acute exacerbation of chronic conditions when services are disrupted, countries should define which essential health services will be prioritised according to the context so that they continue to function during the acute phase of the COVID-19<a class="elsevierStyleCrossRef" href="#bib0020">4</a> pandemic.The WHO's high priority categories include, among others, “auxiliary services, such as basic diagnostic imaging, laboratory services and blood bank services” and "the provision of medicines and supplies and the support of health workers for the uninterrupted treatment of chronic diseases", such as blood components and plasma derivatives.<a class="elsevierStyleCrossRef" href="#bib0020">4</a> Already in 2009, in the case of the A/H1N1 influenza pandemic, the Ministry of Health recommended encouraging donors to receive regular seasonal influenza vaccine and helping them to have priority access to a pandemic vaccine when it becomes available.<a class="elsevierStyleCrossRef" href="#bib0025">5</a>However, in our country's national plan, the essential services, with the exception of health and social-health professionals considered to be the first line, were left in a second or third phase. Thus, health workers are classified into first-line workers, who are vaccinated in the first phase, and second-line workers. Second-line health and social care workers will either be vaccinated in a second phase when their risk of exposure is high or will be moved to a third phase to be included alongside other essential personnel. However, blood donors are not currently covered by any of the priority vaccination phases.<a class="elsevierStyleCrossRef" href="#bib0015">3</a>This is why we believe, in agreement with Drs. Dal-Ré and Camps, that priority should be given to vaccinating vulnerable and high-risk groups of patients in phase 1.<a class="elsevierStyleCrossRef" href="#bib0005">1</a> In line with the philosophy of the H1N1 influenza pandemic coordination plan and WHO recommendations,<a class="elsevierStyleCrossRefs" href="#bib0020">4,5</a> workers in transfusion centres and services should be included in this initial phase to ensure the supply of blood components and derivatives. Then, in phase 2, we encourage the inclusion of non-immunized active blood donors, especially apheresis donors. We also propose that blood donations from vaccinated donors be scheduled 7 days after the second dose of mRNA or non-replicating adenovirus vaccines, not only to reinforce the safety of donors and Transfusion Centre workers but, above all, to ensure that the humoral immunity present in the plasma of their donation has an "extra" benefit by providing passive immunity to the recipients.FundingWithout funding.Conflict of interestsThe authors declare that they have no conflict of interest in relation to the present paper.The corresponding author has received conference grants and fees for courses, lectures and/or teaching material from Uriach-Vifor, Sandoz, Zambon, Jansen. The first author has received conference grants or fees from GSK, Pfizer, Sanofi-Pasteur." "textoCompletoSecciones" => array:1 [ "secciones" => array:4 [ 0 => array:2 [ "identificador" => "sec0005" "titulo" => "Funding" ] 1 => array:2 [ "identificador" => "sec0010" "titulo" => "Conflict of interests" ] 2 => array:2 [ "identificador" => "xack584809" "titulo" => "Acknowledgements" ] 3 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "NotaPie" => array:1 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "Please cite this article as: Rodríguez-García J, Domingo Morera JM, García-Erce JA. Vacunación a donantes de sangre. Med Clin (Barc). 2022;158:144–146." ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:5 [ 0 => array:3 [ "identificador" => "bib0005" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Who should be vaccinated against COVID-19 first?" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "R. Dal-Ré" 1 => "V. Camps" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.medcli.2020.11.001" "Revista" => array:5 [ "tituloSerie" => "Med Clin (Barc)" "fecha" => "2021" "volumen" => "156" "paginaInicial" => "177" "paginaFinal" => "179" ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0010" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:1 [ "titulo" => "The Advisory Committee on Immunization Practices’ Ethical Principles for Allocating Initial Supplies of COVID-19 Vaccine — United States, 2020" ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.15585/mmwr.mm6947e3" "Revista" => array:6 [ "tituloSerie" => "MMWR Morb Mortal Wkly Rep" "fecha" => "2020" "volumen" => "69" "paginaInicial" => "1782" "paginaFinal" => "1786" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/33237895" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0015" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "Documento de Consenso de la Sociedad Espa˜nola de Medicina Preventiva, SaludPública e Higiene sobre la priorización de vacunación frente a SARS-CoV-2 enadultos con condiciones de riesgo. Available from: <a target="_blank" href="https://www.sempsph.com/images/Consenso_Recomendaciones_SEMPSPH_08022021_PDF_MÁS_CLARO1%201.pdf">https://www.sempsph.com/images/Consenso_Recomendaciones_SEMPSPH_08022021_PDF_MÁS_CLARO1%201.pdf</a>." ] ] ] 3 => array:3 [ "identificador" => "bib0020" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "Organización Mundial de la Salud y Programa de las Naciones Unidas parael Desarrollo (PNUD). Hacer frente a las enfermedades no transmisiblesdurante la pandemia de COVID-19 y después de ella. <a target="_blank" href="http://WHO/2019-nCoV/Non-communicablediseases/Policybrief/2020.1">WHO/2019-nCoV/Non-communicablediseases/Policybrief/2020.1</a> 2020." ] ] ] 4 => array:3 [ "identificador" => "bib0025" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "Plan de coordinación pandemia influenza A (H1N1) de 2009, todavía vigenteen la web del Ministerio de Sanidad. Available from: <a target="_blank" href="https://www.mscbs.gob.es/profesionales/saludPublica/medicinaTransfusional/publicaciones/docs/PlanSist.pdf">https://www.mscbs.gob.es/profesionales/saludPublica/medicinaTransfusional/publicaciones/docs/PlanSist.pdf</a>." ] ] ] ] ] ] ] "agradecimientos" => array:1 [ 0 => array:4 [ "identificador" => "xack584809" "titulo" => "Acknowledgements" "texto" => "Dr. Carlos Sola Lapeña. La Rioja Blood Bank.Dr. José Luis Arroyo. Cantabria Blood and Tissue Bank." "vista" => "all" ] ] ] "idiomaDefecto" => "en" "url" => "/23870206/0000015800000003/v1_202202040749/S2387020622000110/v1_202202040749/en/main.assets" "Apartado" => array:4 [ "identificador" => "43309" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Letters to the Editor" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/23870206/0000015800000003/v1_202202040749/S2387020622000110/v1_202202040749/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2387020622000110?idApp=UINPBA00004N"]

ISSN: 2387-0206

Launched in 1943, Medicina Clínica is a fortnightly journal aimed at the promotion of clinical research and practice among internal medicine and other specialists. The key characteristics of Medicina Clínica are the scientific and methodological rigor of its manuscripts, the topicality of its contents, and, especially, its practical focus with highly useful information for clinical practice. Medicina Clínica is predominantly interested in publishing original research manuscripts, which are rigorously selected according to their quality, originality, and interest, and also in continued medical education-oriented manuscripts, which are commissioned by the journal to relevant authors (Editorials, Reviews, and Diagnosis and Treatment). These manuscripts contain updated topics with a major clinical or conceptual relevance in modern medicine. The journal adheres to the standards of academic research publications in all aspects including peer-review and ethical principles. Medicina Clínica is included in the General and Internal Medicine category of Thomson Reuters.

See more Open Access Option

Indexed in:

Current Contents/Clinical Medicine, Journal Citation Reports, SCI-Expanded, Index Medicus/Medline, Excerpta Medica/EMBASE, IBECS, IME, MEDES, PASCAL, SCOPUS, SciVerse ScienceDirect

Subscribe:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2022

Impact factor 2023

2.6

Citescore

CiteScore measures average citations received per document published.

Citescore 2023

3.1

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

SJR 2023

0.371

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

SNIP 2023

0.511

View more metrics

Journal Information

Previous article | Next article

Vol. 158. Issue 3.